| human | Q5 |
| P213 | ISNI | 0000000113693115 |
| P12541 | Ludzie Nauki ID (new) | VTezSJsLf8l |
| P1207 | NUKAT ID | n01021232 |
| P496 | ORCID iD | 0000-0001-7228-2906 |
| P7293 | PLWABN ID | 9810661997605606 |
| P3124 | Polish scientist ID | 15990 |
| P1153 | Scopus author ID | 7004367956 |
| P214 | VIAF ID | 311125984 |
| P512 | academic degree | doctorate | Q849697 |
| habilitation | Q308678 | ||
| scientific professorship degree | Q55695329 | ||
| P27 | country of citizenship | Poland | Q36 |
| P185 | doctoral student | Marcin Basiak | Q11767482 |
| Aleksandra Bołdys | Q86999136 | ||
| Łukasz Bułdak | Q92349975 | ||
| Maciej Haberka | Q98647195 | ||
| P69 | educated at | Medical University of Silesia | Q2239217 |
| P108 | employer | Medical University of Silesia | Q2239217 |
| P734 | family name | Okopień | Q124471984 |
| Okopień | Q124471984 | ||
| Okopień | Q124471984 | ||
| P735 | given name | Bogusław | Q493190 |
| Bogusław | Q493190 | ||
| Antoni | Q17480899 | ||
| Antoni | Q17480899 | ||
| P1412 | languages spoken, written or signed | Polish | Q809 |
| P1559 | name in native language | Bogusław Okopień | |
| P103 | native language | Polish | Q809 |
| P106 | occupation | researcher | Q1650915 |
| internist | Q15924224 | ||
| physician | Q39631 | ||
| pharmacologist | Q2114605 | ||
| P21 | sex or gender | male | Q6581097 |
| Q53772702 | A Neutral Effect of Metformin Treatment on Macroprolactin Content in Women with Macroprolactinemia. |
| Q41737427 | A Novel, Highly Selective RT-QPCR Method for Quantification of MSRV Using PNA Clamping Syncytin-1 (ERVWE1) |
| Q86999987 | A neutral effect of testosterone therapy on macroprolactin content in men with macroprolactinemia and late-onset hypogonadism |
| Q54235330 | A new and improved method based on polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) for the determination of A1298C mutation in the methylenetetrahydrofolate reductase (MTHFR) gene. |
| Q77393894 | A new immunological marker of atherosclerotic injury of arterial wall |
| Q38996505 | A peptide nucleic acid (PNA)-mediated polymerase chain reaction clamping allows the selective inhibition of the ERVWE1 gene amplification. |
| Q44256462 | A successful case of pain management using metformin in a patient with adiposis dolorosa. |
| Q28574541 | AICAR (5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside) increases the production of toxic molecules and affects the profile of cytokines release in LPS-stimulated rat primary microglial cultures |
| Q46333145 | Adrenal disorders in pregnancy |
| Q46328177 | Adrenopause |
| Q46978737 | Advance in treatment of polycystic ovary syndrome |
| Q46478705 | Advances in the treatment of acromegaly |
| Q39991995 | Age may determine the effect of hypolipidemic agents on plasma adipokine levels in patients with elevated low-density lipoprotein cholesterol levels |
| Q89496993 | Alternative Treatment Strategies in Women Poorly Tolerating Moderate Doses of Bromocriptine |
| Q28569880 | Ambivalent effects of compound C (dorsomorphin) on inflammatory response in LPS-stimulated rat primary microglial cultures |
| Q42538670 | Antihypertensive effect of amlodipine compared with nifedipine retard in patients with mild and moderate essential hypertension. |
| Q51388945 | Anti‐Inflammatory and Monocyte‐Suppressing Effects of Simvastatin in Patients with Impaired Fasting Glucose |
| Q83016309 | Atorvastatin and fenofibric acid differentially affect the release of adipokines in the visceral and subcutaneous cultures of adipocytes that were obtained from patients with and without mixed dyslipidemia |
| Q57785252 | Atorvastatin potentiates the effect of selenomethionine on thyroid autoimmunity in euthyroid women with Hashimoto's thyroiditis |
| Q83600575 | Atypical clinical manifestation of antiphospholipid syndrome |
| Q84039260 | Atypical clinical manifestations of multiple endocrine neoplasia type 1 syndrome |
| Q45038869 | Autoimmune polyglandular syndrome type 2 in pregnancy: a case report |
| Q83632521 | Autoimmune polyglandular syndrome type 2 induced by treatment with interferon alpha |
| Q57453174 | Benefits and risks of the treatment with fibrates - a comprehensive summary |
| Q51038834 | Bile bacterial flora and its in vitro resistance pattern in patients with acute cholangitis resulting from choledocholithiasis. |
| Q92660887 | Cardiometabolic Risk Factors in Men with Elevated Macroprolactin Content: A Pilot Study |
| Q90186638 | Cardiometabolic risk factors in women with non-classic congenital adrenal hyperplasia |
| Q92198906 | Cardiometabolic risk factors in young women with macroprolactinaemia |
| Q37215912 | Carotid intima-media thickness in patients with mild or moderate psoriasis. |
| Q95446986 | Chronic adrenal failure and hypergonadotropic hypogonadism in a patient with abetalipoproteinemia |
| Q46241833 | Coadministration of valsartan 160 and 320 mg and simvastatin 20 and 40 mg in patients with hypertension and hypercholesterolemia: a multicenter, 12-week, double-blind, double-dummy, parallel-group superiority study |
| Q57218168 | Coexistence of glucocorticoid resistance and pseudohypoparathyroidism |
| Q48492763 | Coexistence of growth hormone deficiency and autoimmune polyglandular syndrome type 3. |
| Q36110245 | Coexistence of primary aldosteronism and Hashimoto's thyroiditis |
| Q46848632 | Comparison of chosen activation markers of human monocytes/macrophages isolated from the peripheral blood of young and elderly volunteers |
| Q85514062 | Comparison of the effects of hypolipidemic treatment on monocyte proinflammatory cytokine release in men and women with type 2 diabetes and atherogenic dyslipidemia |
| Q87223650 | Comparison of the effects of short-term hypolipidaemic treatment on plasma adipokine levels in men and women with isolated hypercholesterolaemia |
| Q45079578 | Contemporary pharmacological methods of treating hirsutism |
| Q71605310 | Contractility of the tail artery in rats treated with bezafibrate and fed atherogenic diet |
| Q85002634 | Controlling newly diagnosed type 2 diabetes mellitus with metformin managed pain symptoms in a patient affected with Dercum's disease |
| Q87722413 | Corrigendum to "Comparison of chosen activation markers of human monocytes/macrophages isolated from the peripheral blood of young and elderly volunteers" [Pharmacol. Rep. 66 (2014) 759-765] |
| Q93128564 | Corrigendum to "Comparison of chosen activation markers of human monocytes/macrophages isolated from the peripheral blood of young and elderly volunteers'' [Pharmacol. Rep. 66 (2014) 759-765] |
| Q93128568 | Corrigendum to "Eplerenone promotes alternative activation in human monocyte-derived macrophages" [Pharmacol. Rep. 65 (2013) 226-234] |
| Q87722409 | Corrigendum to "Eplerenone promotes alternative activation in human monocyte-derived macrophages" [Pharmacol. Rep. 65 (2013) 226-234] |
| Q93138027 | Corrigendum to "Exenatide (a GLP-1 agonist) expresses anti-inflammatory properties in cultured human monocytes/macrophages in A protein kinase A and B/Akt manner'' [Pharmacol. Rep. 68 (2016) 329-337] |
| Q51145644 | Corrigendum to "Exenatide (a GLP-1 agonist) expresses anti-inflammatory properties in cultured human monocytes/macrophages in a protein kinase A and B/Akt manner" [Pharmacological Reports 68 (2016) 329-337]. |
| Q93128560 | Corrigendum to "Metformin affects macrophages' phenotype and improves the activity of glutathione peroxidase, superoxide dismutase, catalase and decreases malondialdehyde concentration in a partially AMPK-independent manner in LPS-stimulated human m |
| Q87717593 | Corrigendum to "Metformin affects macrophages' phenotype and improves the activity of glutathione peroxidase, superoxide dismutase, catalase and decreases malondialdehyde concentration in a partially AMPK-independent manner in LPS-stimulated human m |
| Q51073778 | Corrigendum to "Metformin has adenosine-monophosphate activated protein kinase (AMPK)-independent effects on LPS-stimulated rat primary microglial cultures" [Pharmacol. Rep. 62 (2010) 827-848]. |
| Q93113800 | Corrigendum to "Metformin has adenosine-monophosphate activated protein kinase (AMPK)-independent effects on LPS-stimulated rat primary microglial cultures'' [Pharmacol. Rep. 62 (2010) 827-848] |
| Q38834676 | Current and future trends in the lipid lowering therapy |
| Q46478700 | Current views on the role of dehydroepiandrosterone in physiology, pathology and therapy |
| Q83819343 | Cyclic Cushing's syndrome |
| Q85918829 | Daily intake and serum concentration of menaquinone-4 (MK-4) in haemodialysis patients with chronic kidney disease |
| Q100420973 | Dehydroepiandrosterone potentiates the effect of vitamin D on thyroid autoimmunity in euthyroid women with autoimmune thyroiditis: a pilot study |
| Q45098930 | Diagnostic difficulties in diagnosis of splenic abscesses |
| Q91060113 | Different Effects of Atorvastatin on Cardiometabolic Risk Factors in Young Women With and Without Hyperprolactinemia |
| Q51297063 | Different Effects of Metformin on the Hypothalamic-Pituitary-Thyroid Axis in Bromocriptine- and Cabergoline-treated Patients with Hashimoto's Thyroiditis and Glucose Metabolism Abnormalities. |
| Q51417569 | Different cardiometabolic effects of atorvastatin in men with normal vitamin D status and vitamin D insufficiency. |
| Q86684536 | Different effects of atorvastatin on metabolic and cardiovascular risk factors in hypercholesterolemic women with normal thyroid function and subclinical hypothyroidism |
| Q87577908 | Different effects of cabergoline and bromocriptine on metabolic and cardiovascular risk factors in patients with elevated prolactin levels |
| Q93371835 | Different effects of fenofibrate on cardiometabolic risk factors in young women with and without hyperprolactinemia |
| Q85700873 | Different effects of fenofibrate on metabolic and cardiovascular risk factors in mixed dyslipidemic women with normal thyroid function and subclinical hypothyroidism |
| Q98614737 | Different effects of metformin on hypothalamic-pituitary-thyroid axis activity in levothyroxine-treated and levothyroxine-naïve women with non-autoimmune hypothyroidism |
| Q86109961 | Different effects of perindopril and enalapril on monocyte cytokine release in coronary artery disease patients with normal blood pressure |
| Q42759119 | Different effects of simvastatin on ex vivo monocyte cytokine release in patients with hypercholesterolemia and impaired glucose tolerance |
| Q40283163 | Difficulties in the diagnosis of painful Hashimoto's thyroiditis--case report |
| Q49683655 | Effect of Metformin on Hypothalamic-Pituitary-Thyroid Axis Activity in Elderly Antipsychotic-Treated Women With Type 2 Diabetes and Subclinical Hypothyroidism: A Preliminary Study |
| Q43191754 | Effect of atorvastatin and fenofibric acid on adipokine release from visceral and subcutaneous adipose tissue of patients with mixed dyslipidemia and normolipidemic subjects. |
| Q51385582 | Effect of bezafibrate on monocyte cytokine release and systemic inflammation in patients with impaired fasting glucose. |
| Q68198756 | Effect of fenofibrate on the tail artery contraction of rats fed with an atherogenic diet |
| Q43447250 | Effect of metformin on selected parameters of hemostasis in fenofibrate-treated patients with impaired glucose tolerance |
| Q46384770 | Effect of monthly atorvastatin and fenofibrate treatment on monocyte chemoattractant protein-1 release in patients with primary mixed dyslipidemia. |
| Q45186475 | Effect of monthly atorvastatin treatment on hemostasis. |
| Q83320902 | Effect of simvastatin and fenofibrate on cytokine release and systemic inflammation in type 2 diabetes mellitus with mixed dyslipidemia |
| Q37865699 | Effect of simvastatin and fluvastatin on plasma fibrinogen levels in patients with primary hypercholesterolemia |
| Q86067218 | Effect of simvastatin on hemostasis in patients with isolated hypertriglyceridemia |
| Q51351991 | Effects of 90-day hypolipidemic treatment on insulin resistance, adipokines and proinflammatory cytokines in patients with mixed hyperlipidemia and impaired fasting glucose. |
| Q35200997 | Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes |
| Q44447370 | Effects of atorvastatin, simvastatin, and fenofibrate therapy on monocyte chemoattractant protein-1 secretion in patients with hyperlipidemia. |
| Q34270969 | Effects of bisoprolol and cilazapril on the central retinal artery blood flow in patients with essential hypertension--preliminary results |
| Q44483994 | Effects of fenofibrate and simvastatin on plasma sICAM-1 and MCP-1 concentrations in patients with hyperlipoproteinemia |
| Q47862536 | Effects of fenofibrate on plasma cytokine concentrations in patients with atherosclerosis and hyperlipoproteinemia IIb. |
| Q43841816 | Effects of fibrates on plasma prothrombotic activity in patients with type IIb dyslipidemia. |
| Q34318487 | Effects of micronized fenofibrate on insulin resistance in patients with metabolic syndrome |
| Q46955983 | Effects of short-term fenofibrate treatment on circulating markers of inflammation and hemostasis in patients with impaired glucose tolerance. |
| Q84753836 | Empty sella syndrome in thyroid cancer survivor |
| Q92349979 | Endocrine diseases as causes of secondary hyperlipidemia |
| Q36033620 | Endocrine symptoms as the initial manifestation of Wilson's disease. |
| Q92670573 | Endogenous testosterone determines metformin action on prolactin levels in hyperprolactinaemic men: A pilot study |
| Q93071961 | Epicardial, paracardial, and perivascular fat quantity, gene expressions, and serum cytokines in patients with coronary artery disease and diabetes |
| Q42453484 | Eplerenone mimics features of the alternative activation in macrophages obtained from patients with heart failure and healthy volunteers |
| Q44876516 | Eplerenone promotes alternative activation in human monocyte-derived macrophages. |
| Q95781006 | Erratum to "Comparison of chosen activation markers of human monocytes/macrophages isolated from the peripheral blood of young and elderly volunteers" |
| Q95780994 | Erratum to "Eplerenone promotes alternative activation in human monocyte-derived macrophages" |
| Q95780988 | Erratum to "Metformin affects macrophages' phenotype and improves the activity of glutathione peroxidase, superoxide dismutase, catalase and decreases malondialdehyde concentration in a partially AMPK-independent manner in LPS-stimulated human monoc |
| Q95780953 | Erratum to "Metformin has adenosine-monophosphate activated protein kinase (AMPK)-independent effects on LPS-stimulated rat primary microglial cultures" |
| Q89204273 | Erratum to: Ambivalent effects of compound C (dorsomorphin) on inflammatory response in LPS-stimulated rat primary microglial cultures |
| Q89204278 | Erratum to: Metformin increases phagocytosis and acidifies lysosomal/endosomal compartments in AMPK-dependent manner in rat primary microglia |
| Q50069484 | Euthyroid sick syndrome: an important clinical problem |
| Q52882844 | Exenatide (a GLP-1 agonist) expresses anti-inflammatory properties in cultured human monocytes/macrophages in a protein kinase A and B/Akt manner. |
| Q35956905 | Exenatide (a GLP-1 agonist) improves the antioxidative potential of in vitro cultured human monocytes/macrophages. |
| Q46515365 | Exenatide and metformin express their anti-inflammatory effects on human monocytes/macrophages by the attenuation of MAPKs and NFκB signaling. |
| Q79330799 | Extralipid effects of micronized fenofibrate in dyslipidemic patients |
| Q37987435 | Ezetimibe--a new approach in hypercholesterolemia management |
| Q49571281 | Fibrates in the management of atherogenic dyslipidemia |
| Q51235454 | Glucocorticoid hypersensitivity syndrome--a case report. |
| Q37019805 | Growth hormone therapy in children and adults |
| Q84862543 | Haemostatic effects of levothyroxine and selenomethionine in euthyroid patients with Hashimoto's thyroiditis |
| Q51355302 | Haemostatic effects of metformin in simvastatin-treated volunteers with impaired fasting glucose. |
| Q51385628 | Haemostatic effects of simvastatin in subjects with impaired glucose tolerance. |
| Q51369235 | Hemostatic effects of bezafibrate and ω-3 fatty acids in isolated hypertriglyceridemic patients. |
| Q42754388 | Hemostatic effects of fenofibrate in patients with mixed dyslipidemia and impaired fasting glucose |
| Q84729591 | Hemostatic effects of omega-3 fatty acids in isolated hypertriglyceridemic patients treated with bezafibrate |
| Q42754391 | Hemostatic effects of simvastatin in subjects with impaired fasting glucose. |
| Q38138109 | Highly organized nanostructures for brain drug delivery--new hope or just a fad? |
| Q36843704 | Hormonal supplementation in endocrine dysfunction in critically ill patients. |
| Q84849071 | Humoral hypercalcemia of malignancy in a patient with hypoparathyroidism |
| Q97566853 | Hyperprolactinaemia attenuates the inhibitory effect of vitamin D/selenomethionine combination therapy on thyroid autoimmunity in euthyroid women with Hashimoto's thyroiditis: A pilot study |
| Q45226976 | Hypolipidemic drugs affect monocyte IL-1beta gene expression and release in patients with IIa and IIb dyslipidemia. |
| Q46691442 | Hypoparathyroidism and hypogonadism as a clinical manifestation of hemochromatosis |
| Q83777928 | Hypoparathyroidism in pregnancy |
| Q92600027 | Impact of Macroprolactinemia on Cardiometabolic Effects of Atorvastatin in Women With Hypercholesterolemia |
| Q103014484 | Impact of dehydroepiandrosterone on thyroid autoimmunity and function in men with autoimmune hypothyroidism |
| Q38078668 | Incretin-based therapies in the treatment of type 2 diabetes--more than meets the eye? |
| Q37630869 | Inhibitors of type 2 sodium glucose co-transporters--a new strategy for diabetes treatment |
| Q46118629 | Inhibitory effect of carbamazepine on hypotensive action of spironolactone in primary aldosteronism |
| Q43555017 | Levels of sICAM-1, sVCAM-1 and MCP-1 in patients with hyperlipoproteinemia IIa and -IIb |
| Q83016319 | Lymphocyte-suppressing action of angiotensin-converting enzyme inhibitors in coronary artery disease patients with normal blood pressure |
| Q46864003 | Lymphocyte-suppressing action of simvastatin in patients with isolated hypertriglyceridemia |
| Q51349769 | Lymphocyte-suppressing and systemic anti-inflammatory effects of high-dose metformin in simvastatin-treated patients with impaired fasting glucose. |
| Q51375949 | Lymphocyte-suppressing effect of simvastatin in mixed dyslipidemic patients but not impaired glucose tolerance patients. |
| Q84729584 | Lymphocyte-suppressing effects of omega-3 fatty acids in bezafibrate-treated patients with isolated hypertriglyceridemia |
| Q44071072 | Lymphocyte-suppressing, endothelial-protective and systemic anti-inflammatory effects of metformin in fenofibrate-treated patients with impaired glucose tolerance |
| Q92838256 | Macroprolactinaemia modulates cardiometabolic effects of fenofibrate in men with atherogenic dyslipidaemia: A pilot study |
| Q96134418 | Macroprolactinemia Attenuates the Impact of Levothyroxine on Hypothalamic-Pituitary-Thyroid Axis Activity and Thyroid Autoimmunity in Women With Autoimmune Hypothyroidism |
| Q43111569 | Metabolic and monocyte-suppressing actions of fenofibrate in patients with mixed dyslipidemia and early glucose metabolism disturbances |
| Q46883164 | Metformin affects macrophages' phenotype and improves the activity of glutathione peroxidase, superoxide dismutase, catalase and decreases malondialdehyde concentration in a partially AMPK-independent manner in LPS-stimulated human monocytes/macroph |
| Q42794541 | Metformin has adenosine-monophosphate activated protein kinase (AMPK)-independent effects on LPS-stimulated rat primary microglial cultures |
| Q43220591 | Metformin increases phagocytosis and acidifies lysosomal/endosomal compartments in AMPK-dependent manner in rat primary microglia. |
| Q42316779 | Metformin reduces the expression of NADPH oxidase and increases the expression of antioxidative enzymes in human monocytes/macrophages cultured in vitro |
| Q36640261 | Metformin reduces the expression of NADPH oxidase and increases the expression of antioxidative enzymes in human monocytes/macrophages cultured in vitro. |
| Q94585117 | Metformin therapy in pregnancy [Zastosowanie metforminy w ciąży] |
| Q51032857 | Methyltestosterone-induced transient hyperthyroidism in a hypothyroid patient. |
| Q90598409 | Mild to moderate psoriasis is associated with oxidative stress, subclinical atherosclerosis, and endothelial dysfunction |
| Q50054449 | Moderate-dose simvastatin therapy potentiates the effect of vitamin D on thyroid autoimmunity in levothyroxine-treated women with Hashimoto's thyroiditis and vitamin D insufficiency. |
| Q46961124 | Modern pharmacotherapy of benign prostatic hyperplasia |
| Q71617506 | Modification of adrenergic reactivity in rat tail artery by dietary lipids and calcium channel antagonists |
| Q48291442 | Monitoring the Transcriptional Activity of Human Endogenous Retroviral HERV-W Family Using PNA Strand Invasion into Double-Stranded DNA. |
| Q46664306 | Monocyte release of tumor necrosis factor-alpha and interleukin-1beta in primary type IIa and IIb dyslipidemic patients treated with statins or fibrates |
| Q46573090 | Monocyte suppressing action of fenofibrate |
| Q83168051 | Monocyte-suppressing effect of bezafibrate but not omega-3 fatty acids in patients with isolated hypertriglyceridaemia |
| Q54364093 | Monocyte-suppressing effect of high-dose metformin in fenofibrate-treated patients with impaired glucose tolerance. |
| Q43619209 | Monocyte-suppressing effects of simvastatin in patients with isolated hypertriglyceridemia. |
| Q86476765 | Multifactorial effects of vildagliptin added to ongoing metformin therapy in patients with type 2 diabetes mellitus |
| Q67863493 | New accomplishments in the pharmacotherapy of bronchial asthma--nedocromil |
| Q40037113 | Obesity, ultrasound indexes of fat depots and lipid goal attainment in patients with high and very high cardiovascular risk: A novel approach towards better risk reduction. |
| Q84703054 | Omega-3 fatty acids enhance monocyte-suppressing effect of bezafibrate in patients with isolated hypertriglyceridemia |
| Q41441015 | Oncolytic viruses as a new way of treatment of neoplastic diseases |
| Q45388657 | Peripartum cardiomyopathy, acute autoimmune pancreatitis and periadipose tissue inflammation - autoimmune reaction? |
| Q100544463 | Perivascular fat of the internal mammary artery in patients with severe coronary artery atherosclerosis |
| Q40224789 | Pharmacologists in the camps In the Third Reich--part one |
| Q43888222 | Pharmacologists in the camps in the Third Reich--part second |
| Q57645813 | Pituitary disorders in pregnancy and after delivery |
| Q82107478 | Plasma concentrations of adhesion molecules and chemokines in patients with essential hypertension |
| Q47777627 | Plasma cytokines as predictors of coronary heart disease. |
| Q98566714 | Plasma gonadotropin levels in metformin-treated men with prediabetes: a non-randomized, uncontrolled pilot study |
| Q43265209 | Pleiotropic action of ACE-I and fibrates |
| Q42164828 | Pleiotropic action of short-term metformin and fenofibrate treatment, combined with lifestyle intervention, in type 2 diabetic patients with mixed dyslipidemia |
| Q46361256 | Pleiotropic effects of angiotensin-converting enzyme inhibitors in normotensive patients with coronary artery disease. |
| Q34153553 | Pleiotropic effects of atorvastatin and fenofibrate in metabolic syndrome and different types of pre-diabetes |
| Q44383727 | Pleiotropic effects of micronized fenofibrate in patients with combined hyperlipidemia |
| Q39018706 | Porcine endogenous retrovirus (PERV) infection of HEK-293 cell line alters expression of human endogenous retrovirus (HERV-W) sequences |
| Q51544579 | Postpartum hypothalamic dysfunction--a case report |
| Q46605677 | Postpartum thyroiditis: current views on unappreciated disease |
| Q84583291 | Potential benefit of paracetamol administration in adult-onset Still's disease |
| Q43144278 | Potentiation of Endocrine Adverse Effects of Lithium by Enalapril and Verapamil |
| Q35569320 | Progress in pharmacotherapy of thrombosis |
| Q43285784 | Prolactinoma |
| Q42794498 | Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide |
| Q34475140 | Recent insights into body weight control: from physiology to pathology |
| Q46671082 | Recent insights into the role of aldosterone in physiology, pathology and therapy |
| Q35161295 | Recurrent pancreatitis induced by hyperparathyroidism in pregnancy |
| Q42856501 | Recurrent pregnancy-induced diabetes insipidus in a woman with hemochromatosis |
| Q46335441 | Relapse of asthma after surgical treatment of Cushing's syndrome. |
| Q38067258 | Role of the SOCS in monocytes/macrophages-related pathologies. Are we getting closer to a new pharmacological target? |
| Q61012054 | SELENOMETHIONINE POTENTIATES THE IMPACT OF VITAMIN D ON THYROID AUTOIMMUNITY IN EUTHYROID WOMEN WITH HASHIMOTO’S THYROIDITIS AND LOW VITAMIN D STATUS |
| Q38075516 | SOCS and diabetes--ups and downs of a turbulent relationship. |
| Q85959915 | Serum 25-Hydroxyvitamin D and Parathyroid Hormone Levels in Non-Lactating Women with Post-Partum Thyroiditis: The Effect of L-Thyroxine Treatment |
| Q44019339 | Severe aortic stenosis disease, left main coronary artery and papillary thyroid cancer: therapeutic dilemmas |
| Q49712561 | Sex-Dependent Effect of Metformin on Serum Prolactin Levels In Hyperprolactinemic Patients With Type 2 Diabetes: A Pilot Study |
| Q48535080 | Sex-dependent effect of metformin on hypothalamic-pituitary-thyroid axis activity in patients with subclinical hypothyroidism. |
| Q48066621 | Sexual Function and Depressive Symptoms in Young Women With Nonclassic Congenital Adrenal Hyperplasia |
| Q47986871 | Sexual Functioning and Depressive Symptoms in Women with Diabetes and Prediabetes Receiving Metformin Therapy: A Pilot Study. |
| Q88626660 | Sexual Functioning in Hyperprolactinemic Patients Treated With Cabergoline or Bromocriptine |
| Q57280421 | Sexual function and depressive symptoms in men with overt hyperthyroidism |
| Q63386324 | Sexual function and depressive symptoms in men with overt hyperthyroidism |
| Q47659619 | Sexual function and depressive symptoms in young men with hypothyroidism receiving levothyroxine/liothyronine combination therapy |
| Q36990087 | Sexual function and depressive symptoms in young women with elevated macroprolactin content: a pilot study |
| Q97557360 | Sexual function and depressive symptoms in young women with hypoprolactinemia |
| Q87974746 | Sexual function and depressive symptoms in young women with hypothyroidism receiving levothyroxine/liothyronine combination therapy: a pilot study |
| Q48019435 | Sexual function and depressive symptoms in young women with low vitamin D status: a pilot study. |
| Q60698294 | Sexual function and depressive symptoms in young women with overt hyperthyroidism |
| Q48073505 | Sexual function and depressive symptoms in young women with thyroid autoimmunity and subclinical hypothyroidism. |
| Q90524410 | Sexual functioning and depressive symptoms in men with various types of prediabetes: a pilot study |
| Q89307478 | Sexual functioning and depressive symptoms in women with various types of prediabetes - a pilot study |
| Q40947780 | Sheehan's syndrome--a forgotten disease with 100 years' history |
| Q53654878 | Short-term antihypertensive therapy lowers the C-reactive protein level. |
| Q43594528 | Subclinical thyroid disorders |
| Q67984574 | Synthesis, structure and biological activity of 1,2,4-triazolo-1,3-thiazine derivatives |
| Q86952977 | TREATMENT WITH CINACALCET INCREASES PLASMA ADIPONECTIN CONCENTRATION IN HEMODIALYZED PATIENTS WITH CHRONIC KIDNEY DISEASE AND SECONDARY HYPERPARATHYROIDISM |
| Q41610640 | The Effect of Atorvastatin on Cardiometabolic Risk Factors in Bromocriptine-Treated Premenopausal Women with Isolated Hypercholesterolemia. |
| Q39362220 | The Effect of Ezetimibe/Statin Combination and High-Dose Statin Therapy on Thyroid Autoimmunity in Women with Hashimoto's Thyroiditis and Cardiovascular Disease: A Pilot Study. |
| Q60395814 | The Effect of Gluten-Free Diet on Thyroid Autoimmunity in Drug-Naïve Women with Hashimoto’s Thyroiditis: A Pilot Study |
| Q50104771 | The Effect of Hypolipidemic Agents on Thyroid Autoimmunity in Women with Hashimoto's Thyroiditis Treated with Levothyroxine and Selenomethionine |
| Q86783354 | The Effect of Metformin and Metformin-Testosterone Combination on Cardiometabolic Risk Factors in Men with Late-onset Hypogonadism and Impaired Glucose Tolerance |
| Q48892384 | The Effect of Metformin on Hypothalamic-Pituitary-Thyroid Axis Activity in Women with Interferon-Induced Hypothyroidism: A Pilot Study. |
| Q88028661 | The Effect of Metformin on Serum Gonadotropin Levels in Postmenopausal Women with Diabetes and Prediabetes: A Pilot Study |
| Q63987516 | The Effect of Selenomethionine on Thyroid Autoimmunity in Euthyroid Men With Hashimoto Thyroiditis and Testosterone Deficiency |
| Q42792235 | The Effect of Simvastatin on Lymphocyte Secretory Function in Patients With Impaired Fasting Glucose |
| Q87182399 | The Effect of Simvastatin on Plasma Steroid Hormone Levels in Metformin-Treated Women with Non-Classic Congenital Adrenal Hyperplasia |
| Q85270623 | The Effect of Testosterone and Fenofibrate, Administered Alone or in Combination, on Cardiometabolic Risk Factors in Men with Late-Onset Hypogonadism and Atherogenic Dyslipidemia |
| Q51202206 | The Effect of Vitamin D on Thyroid Autoimmunity in Levothyroxine-Treated Women with Hashimoto's Thyroiditis and Normal Vitamin D Status. |
| Q92988613 | The Impact of Ethinyl Estradiol on Metformin Action on Prolactin Levels in Women with Hyperprolactinemia |
| Q92466685 | The Impact of Testosterone on Metformin Action on Hypothalamic-Pituitary-Thyroid Axis Activity in Men: A Pilot Study |
| Q100960601 | The Impact of Vitamin D Status on Cardiometabolic Effects of Fenofibrate in Women with Atherogenic Dyslipidemia |
| Q60395816 | The Relationship Between Statin Action On Thyroid Autoimmunity And Vitamin D Status: A Pilot Study |
| Q47969669 | The application of strand invasion phenomenon, directed by peptide nucleic acid (PNA) and single-stranded DNA binding protein (SSB) for the recognition of specific sequences of human endogenous retroviral HERV-W family. |
| Q85606731 | The association between macroprolactin levels and vitamin D status in premenopausal women with macroprolactinemia: a pilot study |
| Q84475366 | The dawn phenomenon and the Somogyi effect - two phenomena of morning hyperglycaemia |
| Q46098919 | The effect of aggressive rosuvastatin treatment on steroid hormone production in men with coronary artery disease. |
| Q42985950 | The effect of angiotensin-converting enzyme inhibitors on plasma adipokine levels in normotensive patients with coronary artery disease. |
| Q85886122 | The effect of atorvastatin and atorvastatin-ezetimibe combination therapy on androgen production in hyperandrogenic women with elevated cholesterol levels |
| Q90017823 | The effect of atorvastatin on cardiometabolic risk factors in women with non-classic congenital adrenal hyperplasia: A pilot study |
| Q91797176 | The effect of atorvastatin on sexual function and depressive symptoms in young women with elevated cholesterol levels - a pilot study |
| Q35332645 | The effect of bezafibrate and omega-3 fatty acids on lymphocyte cytokine release and systemic inflammation in patients with isolated hypertriglyceridemia |
| Q87862198 | The effect of bromocriptine treatment on sexual functioning and depressive symptoms in women with mild hyperprolactinemia |
| Q83581052 | The effect of ezetimibe and simvastatin on hemostasis in patients with isolated hypercholesterolemia |
| Q83378944 | The effect of ezetimibe and simvastatin on monocyte cytokine release in patients with isolated hypercholesterolemia |
| Q88032167 | The effect of ezetimibe on adipose tissue hormones in patients with isolated hypercholesterolemia |
| Q46668688 | The effect of ezetimibe on androgen production in hypercholesterolemic women with polycystic ovary syndrome. |
| Q84220525 | The effect of ezetimibe, administered alone or in combination with simvastatin, on lymphocyte cytokine release in patients with elevated cholesterol levels |
| Q86824779 | The effect of ezetimibe-statin combination on steroid hormone production in men with coronary artery disease and low cholesterol levels |
| Q86999994 | The effect of fenofibrate on cardiometabolic risk factors in bromocriptine-treated women with mixed dyslipidemia: A pilot study |
| Q42939291 | The effect of fenofibrate on lymphocyte cytokine release in patients with impaired fasting glucose and impaired glucose tolerance: a preliminary report. |
| Q46962775 | The effect of fenofibrate on lymphocyte release of proinflammatory cytokines and systemic inflammation in simvastatin-treated patients with atherosclerosis and early glucose metabolism disturbances. |
| Q87307729 | The effect of hypolipidemic treatment on monocyte cytokine release in different age groups of patients with type 2 diabetes and atherogenic dyslipidemia |
| Q38896429 | The effect of l-thyroxine treatment on sexual function and depressive symptoms in men with autoimmune hypothyroidism. |
| Q83915361 | The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto's thyroiditis |
| Q89423030 | The effect of low vitamin D status on sexual functioning and depressive symptoms in apparently healthy men: a pilot study |
| Q51318458 | The effect of metformin on androgen production in diabetic women with non-classic congenital adrenal hyperplasia. |
| Q51353392 | The effect of metformin on monocyte secretory function in simvastatin-treated patients with impaired fasting glucose. |
| Q51289412 | The effect of metformin on prolactin levels in patients with drug-induced hyperprolactinemia. |
| Q48874159 | The effect of metformin on the hypothalamic-pituitary-thyroid axis in patients with type 2 diabetes and amiodarone-induced hypothyroidism. |
| Q48340925 | The effect of metformin on the hypothalamic-pituitary-thyroid axis in patients with type 2 diabetes and subclinical hyperthyroidism |
| Q48627666 | The effect of metformin on the hypothalamic-pituitary-thyroid axis in women with polycystic ovary syndrome and subclinical hypothyroidism. |
| Q51368832 | The effect of oral contraception on cardiometabolic risk factors in women with elevated androgen levels. |
| Q86231631 | The effect of oral contraception on macroprolactin levels in women with macroprolactinemia: A pilot study |
| Q42793481 | The effect of perindopril and enalapril on plasma resistin levels in normotensive patients with coronary heart disease |
| Q85245553 | The effect of short-term combined treatment with simvastatin and ezetimibe on circulating adipokine levels in patients with isolated hypercholesterolemia |
| Q35546563 | The effect of short-term metformin treatment on plasma prolactin levels in bromocriptine-treated patients with hyperprolactinaemia and impaired glucose tolerance: a pilot study |
| Q91797224 | The effect of short-term perindopril and telmisartan treatment on circulating levels of anti-inflammatory cytokines in hypertensive patients |
| Q87643643 | The effect of short-term simvastatin treatment on plasma adipokine levels in patients with isolated hypercholesterolemia: A preliminary report |
| Q51201563 | The effect of simvastatin treatment on plasma steroid levels in females with non-classic congenital adrenal hyperplasia. |
| Q86979961 | The effect of simvastatin-ezetimibe combination therapy on adipose tissue hormones and systemic inflammation in patients with isolated hypercholesterolemia |
| Q90104246 | The effect of spironolactone on thyroid autoimmunity in euthyroid men with Hashimoto's thyroiditis |
| Q87384182 | The effect of statin therapy on thyroid autoimmunity in patients with Hashimoto's thyroiditis: A pilot study |
| Q45068326 | The effect of statins and fibrates on interferon-gamma and interleukin-2 release in patients with primary type II dyslipidemia |
| Q86999996 | The effect of testosterone on cardiometabolic risk factors in atorvastatin-treated men with late-onset hypogonadism |
| Q86999980 | The effect of testosterone on cardiovascular risk factors in men with type 2 diabetes and late-onset hypogonadism treated with metformin or glimepiride |
| Q92650282 | The effect of testosterone on thyroid autoimmunity in euthyroid men with Hashimoto's thyroiditis and low testosterone levels |
| Q84820165 | The effect of treatment on monocyte and lymphocyte cytokine release in patients with aldosteronoma |
| Q61012056 | The effect of vitamin D and selenomethionine on thyroid antibody titers, hypothalamic-pituitary-thyroid axis activity and thyroid function tests in men with Hashimoto’s thyroiditis: a pilot study |
| Q63386339 | The effect of vitamin D on thyroid autoimmunity in euthyroid men with autoimmune thyroiditis and testosterone deficiency |
| Q87060598 | The effect of vitamin D on thyroid autoimmunity in non-lactating women with postpartum thyroiditis |
| Q50016115 | The effect of vitamin D supplementation on sexual functioning and depressive symptoms in young women with low vitamin D status |
| Q43258812 | The effects of 1 month antihypertensive treatment with perindopril, bisoprolol or both on the ex vivo ability of monocytes to secrete inflammatory cytokines |
| Q38305907 | The emering role of helminths in treatment of the inflammatory bowel disorders. |
| Q97647436 | The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome |
| Q97686320 | The impact of combination therapy with metformin and exogenous vitamin D on hypothalamic-pituitary-thyroid axis activity in women with autoimmune thyroiditis and high-normal thyrotropin levels |
| Q49645442 | The impact of electronic cigarettes usage on the endothelial function and the progression of atherosclerosis |
| Q64271326 | The impact of exenatide (a GLP-1 agonist) on markers of inflammation and oxidative stress in normal human astrocytes subjected to various glycemic conditions |
| Q92428016 | The impact of oral hormonal contraception on metformin action on hypothalamic-pituitary-thyroid axis activity in women with diabetes and prediabetes: A pilot study |
| Q33883204 | The influence of ezetimibe on classical and alternative activation pathways of monocytes/macrophages isolated from patients with hypercholesterolemia |
| Q38242473 | The latest achievements in the pharmacotherapy of gambling disorder |
| Q34664893 | The newest perspectives on the treatment of glioblastoma multiforme |
| Q45247541 | The risk of atherosclerosis in patients with impaired glucose tolerance. |
| Q46516381 | The role of TLR4 receptor in development of inflammation and carcinogenesis in ulcerative colitis and pharmacotherapy of this disorder |
| Q36095970 | The role of adipokines in connective tissue diseases. |
| Q46823061 | The testosterone therapy in patients with andropause |
| Q46946527 | Thyroid disorders in pregnancy and after delivery |
| Q54299751 | Thyrotropin-lowering effect of metformin in a patient with resistance to thyroid hormone. |
| Q89027042 | Treatment Based on Cinacalcet Reduces Oxidative Stress in Hemodialysis Patients with Secondary Hyperparathyroidism |
| Q84227240 | Unfavorable effects of hyperprolactinemia in autoimmune endocrine disorders |
| Q36645516 | Update on the management of polycystic ovary syndrome. |
| Q44637754 | Vascular action of natural vasopressin-like peptides in isolated rat tail artery |
| Q81129815 | [A rare association of postpartum thyroiditis and ulcerative colitis] |
| Q95388441 | [Actual diagnosis, treatment and prevention of human granulocytic anaplasmosis] |
| Q82849351 | [Adipose tissue: a new endocrine organ] |
| Q95479485 | [Adrenal insufficiency] |
| Q85001592 | [Advances in the diagnosis and treatment of Zollinger-Ellison syndrome] |
| Q83386231 | [Advances in the etiopathogenesis, diagnosis and treatment of paragangliomas] |
| Q79763900 | [An unusual clinical presentation of the autoimmune polyendocrine syndrome] |
| Q81120748 | [Anabolic therapy in osteoporosis--part 1] |
| Q81283965 | [Anabolic therapy of osteoporosis] |
| Q80272783 | [Aromatase inhibitors] |
| Q74085404 | [Atherosclerotic injury to arteries in patients with chronic infections--immunopathologic factors and risk of coronary disease] |
| Q82268204 | [Atypical clinical presentation of autoimmune polyglandular syndrome type 4] |
| Q80145392 | [Atypical clinical presentation of pseudohypoparathyroidism coexisting with autoimmune disorders] |
| Q84556108 | [Atypical pituitary tumors] |
| Q83449306 | [Autoimmune polyendocrine syndrome type 3 in a patient after surgical treatment of Cushing syndrome] |
| Q52666770 | [Autoimmune polyglandular syndrome type 1-like clinical picture of hereditary hemochromatosis]. |
| Q82190535 | [Beta-adrenolitics in therapy of cardiovascular diseases in patients with type 2 diabetes mellitus] |
| Q80850260 | [Carbamazepine-induced hyponatremia] |
| Q83612725 | [Central precocious puberty] |
| Q95541468 | [Cerebral salt wasting syndrome in a patient with posttraumatic brain injury] |
| Q95519217 | [Clinical aspects of the use of trimetazidine in the prevention and treatment of myocardial diseases] |
| Q85609340 | [Coexistence of autoimmune polyglandular syndrome type 3 with diabetes insipidus] |
| Q57645088 | [Coexistence of resistance to thyroid hormone with pituitary incidentaloma] |
| Q83366096 | [Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency] |
| Q95568503 | [Contemporary dermatological methods of treating hirsutism] |
| Q81345210 | [Current concepts on diagnosis and treatment of carcinoid] |
| Q84556114 | [Current opinions on the etiology and pathophysiology of hirsutism] |
| Q74092484 | [Current pharmacotherapy of obesity] |
| Q64040138 | [Current views on etiology, pathophysiology and clinical manifestations of acromegaly] |
| Q54349217 | [Designing and optimization of real-time RT-PCR technique for the detection of hepatitis C virus (HCV) genome in blood serum as internal laboratory quality control]. |
| Q77854015 | [Detectable plasma markers of atherosclerotic artery injuries] |
| Q51346809 | [Diabetes and prediabetes in endocrine disorders]. |
| Q95376049 | [Diabetes insipidus] |
| Q84792119 | [Diagnosis and management of hirsutism] |
| Q84086344 | [Diagnosis and treatment of craniopharyngioma] |
| Q95364790 | [Drug-induced changes in adrenal cortex function] |
| Q95541465 | [Drug-induced exacerbation of hypoaldosteronism in autoimmune polyglandular syndrome type 2] |
| Q85269301 | [Drug-induced thyroid dysfunctions] |
| Q85855956 | [Drugs malabsorption after bariatric surgery] |
| Q45918564 | [Endocrine abnormalities in HIV-infected patients]. |
| Q95516786 | [Endocrine abnormalities in liver diseases] |
| Q85286101 | [Endocrine abnormalities in patients with chronic renal failure - part II] |
| Q53667077 | [Endocrine abnormalities in patients with chronic renal failure - part I]. |
| Q79678145 | [Etiology, histopathological picture and clinical presentation of craniopharyngioma] |
| Q86031350 | [Fecal transplantation the future therapy?] |
| Q53769634 | [Fibrates - the present state of art]. |
| Q95370913 | [Fibrates in the light of large clinical trials] |
| Q81213955 | [Gonadotropin-releasing hormone analogs] |
| Q81353878 | [Growth hormone deficiency in adults] |
| Q82650972 | [Growth hormone deficiency in children and adults] |
| Q80763081 | [Growth hormone therapy] |
| Q84086346 | [Gynecomastia] |
| Q82227012 | [Hyperprolactinaemia--like symptoms in Wilson's disease] |
| Q95603054 | [Hyperprolactinemia unrelated to prolactinoma] |
| Q95471891 | [Hyperthermic intraperitoneal chemotherapy as a new way of peritoneal metastases treatment] |
| Q80090552 | [Hyperthyroidism in pregnancy] |
| Q95386807 | [Hypoaldosteronism] |
| Q84610014 | [Hyponatremic hypervolemia in heart failure--the hot spot for vasopressin receptor antagonists?] |
| Q95396090 | [Hypoparathyroidism: the present state of art] |
| Q81074540 | [Hypophysitis] |
| Q84792115 | [Hypothyroidism in pregnancy] |
| Q53518730 | [Incidentaloma--one of the greatest challenges of modern endocrinology]. |
| Q50803865 | [Insulinoma]. |
| Q80821759 | [Is every case of muscle damage during hypolipemic therapy the side effect of this therapy? A case report] |
| Q77370829 | [Levels of tumor necrosis factor alpha in serum of patients with hyperlipoproteinemia IIB before and after micronized fenofibrate therapy] |
| Q95425499 | [Lipodystrophy: a new insight into an old disease] |
| Q85269286 | [Lithium carbonate-induced hyperparathyroidism in a patient after removal of a parathyroid adenoma] |
| Q85413799 | [Lithium carbonate-induced hyperparathyroidism in a patient after removal of a parathyroid adenoma] |
| Q79153435 | [Markers of inflammatory process in stable and unstable coronary artery disease] |
| Q73237125 | [Mechanisms of non-lipid dependent effects of statins] |
| Q79775357 | [Medullary thyroid cancer - the present state of art] |
| Q54365222 | [Metformin as a key to alternative activation of microglia?]. |
| Q82558336 | [Modern medical therapy of acromegaly] |
| Q81431842 | [Monogenic forms of mineralocorticoid hypertension] |
| Q84145033 | [Multiple endocrine neoplasia type 1] |
| Q84397876 | [Multiple endocrine neoplasia type 2] |
| Q95521622 | [Nelson's Syndrome] |
| Q83365957 | [Nephrogenic diabetes insipidus induced by colchicine--a case report] |
| Q79763951 | [Normoaldosterone spironolactone sensitive hypertension--a case report] |
| Q80054110 | [Normoaldosterone spironolactone sensitive hypertension] |
| Q95508966 | [Novel strategies of ovarian cancer treatment] |
| Q95415416 | [Ocular symptoms in rheumatic diseases] |
| Q53910915 | [Paraneoplastic endocrine syndromes]. |
| Q64045228 | [Parathyroid carcinoma] |
| Q83595673 | [Pathogenesis and clinical presentation of andropause] |
| Q82364387 | [Peripheral precocious puberty] |
| Q54613918 | [Pituitary disorders in elderly patients]. |
| Q95479561 | [Pituitary disorders in patients after traumatic brain injury and radiotherapy] |
| Q74160022 | [Pleiotropic effects of fibrates] |
| Q52560859 | [Postpartum thyroiditis as the first clinical manifestation of autoimmune polyendocrine syndrome type 2 – case report]. |
| Q79153271 | [Postparum thyroiditis] |
| Q95619879 | [Precocious puberty in boys] |
| Q80054152 | [Precocious puberty] |
| Q82091075 | [Primary aldosteronism in a patient after surgical treatment of primary hyperparathyroidism] |
| Q81535327 | [Primary aldosteronism--new insight into an old disease] |
| Q80468608 | [Primary aldosteronism] |
| Q79763972 | [Primary hyperparathyroidism] |
| Q81313584 | [Proatherogenic lipid metabolism disturbances in impaired glucose tolerance] |
| Q82849362 | [Prostate cancer chemoprevention] |
| Q95603046 | [Radioiodine--today's trends in treatment of benign thyroid diseases] |
| Q95579172 | [Rare abnormalities of parathyroid gland function and parathyroid hormone receptor action] |
| Q85461114 | [Rare causes of Cushing's syndrome] |
| Q64044471 | [Rare congenital defects of adrenal steroidogenesis] |
| Q64043498 | [Rare disorders of glucocorticoid production, metabolism and action] |
| Q64044488 | [Rare pancreatic endocrine tumors] |
| Q95510577 | [Rarer causes of thyrotoxicosis] |
| Q85241382 | [Right atrial tumour and right ventricular failure - diagnostic role of echocardiography and cardiovascular magnetic resonance] |
| Q85269312 | [Safety of bariatric surgery in women of childbearing age and its future impact on their offspring] |
| Q85855559 | [Secondary hypogonadism after traumatic brain injury: a case report] |
| Q85186300 | [Selected endocrine abnormalities in eating disorders] |
| Q53985912 | [Selective estrogen receptor modulators]. |
| Q84686965 | [Somatopause: the present state-of-art] |
| Q81095512 | [Somatostatin analogs] |
| Q46801311 | [Subclinical hyperthyroidism]. |
| Q46306549 | [Subclinical hypothyroidism]. |
| Q85363745 | [Syndrome of inappropriate secretion of antidiuretic hormone] |
| Q83989992 | [The effect of oxcarbamazepine on the clinical effectiveness of dopamine agonists in the treatment of prolactinoma] |
| Q75214513 | [The role of calcium-sensing receptors in physiology, pathology and therapy] |
| Q52563300 | [Thyroid and aging: the present state of art]. |
| Q83366085 | [Thyroid hormone resistance syndrome] |
| Q83595676 | [Treatment of patients with andropause] |
| Q81661962 | [Usage of beta-adrenolytic agents in patients with chronic pulmonary obstructive disease] |
| Q84686958 | [Veno-occlusive disease of the liver] |
| Q83448982 | [Vitamin K, bone metabolism and vascular calcification in chronic kidney disease] |
| Q80840288 | [Whipple's triad as a clinical manifestation of hepatolenticular degeneration] |
Search more.